AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2013
Aug 5, 2013
30718_dirs_2013-08-05_1dce74f8-1a4d-4bfc-9f2e-a4e463a2e0ba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2013-08-01
Reporting Person: REAGAN KEVIN J (Senior VP Biotech)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $70.96 | 2019-01-23 | Common Stock (10773) | Direct | |
| Stock Option (Right to Buy) | $70.96 | 2019-01-23 | Common Stock (4227) | Direct | |
| Stock Option (Right to Buy) | $74.05 | 2019-07-26 | Common Stock (516) | Direct |
Footnotes
F1: Vests 3,591 shares on January 24, 2013, January 24, 2014, and January 24, 2015.
F2: Vests 1,409 shares on January 24, 2013, January 24, 2014, and January 24, 2015.
F3: Fully exercisable.
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4